ESTHER BRAUN: Open Payments
NPI 1699819896 · PIKESVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 20 payments from 11 companies in 2025. Trend: 2023 $428 · 2024 $537 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $98 |
| Sage Therapeutics, LLC | 3 | $78 |
| Aspira Women's Health Inc | 2 | $38 |
| Exeltis, USA Inc. | 2 | $36 |
| MILLICENT US INC | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| Hologic Sales and Service, LLC | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $20 |
| CooperSurgical, Inc. | 1 | $16 |
Products named: Veozah, ZURZUVAE, OVA1, SLYND, INTRAROSA, GARDASIL 9, APTIMA, JOURNAVX.
Industry payments across MD — which companies pay providers there.
